AIMS: Cardiolipin (CL) is a tetra-acyl phospholipid that provides structural and functional support to several proteins in the inner mitochondrial membrane. The majority of CL in the healthy mammalian heart contains four linoleic acid acyl chains (L(4)CL). A selective loss of L(4)CL is associated with mitochondrial dysfunction and heart failure in humans and animal models. We examined whether supplementing the diet with linoleic acid would preserve cardiac L(4)CL and attenuate mitochondrial dysfunction and contractile failure in rats with hypertensive heart failure. METHODS AND RESULTS: Male spontaneously hypertensive heart failure rats (21 months of age) were administered diets supplemented with high-linoleate safflower oil (HLSO) or lard (10% w/w; 28% kilocalorie fat) or without supplemental fat (control) for 4 weeks. HLSO preserved L(4)CL and total CL to 90% of non-failing levels (vs. 61-75% in control and lard groups), and attenuated 17-22% decreases in state 3 mitochondrial respiration observed in the control and lard groups (P < 0.05). Left ventricular fractional shortening was significantly higher in HLSO vs. control (33 ± 2 vs. 29 ± 2%, P < 0.05), while plasma insulin levels were lower (5.4 ± 1.1 vs. 9.1 ± 2.3 ng/mL; P < 0.05), with no significant effect of lard supplementation. HLSO also increased serum concentrations of several eicosanoid species compared with control and lard diets, but had no effect on plasma glucose or blood pressure. CONCLUSION: Moderate consumption of HLSO preserves CL and mitochondrial function in the failing heart and may be a useful adjuvant therapy for this condition.
AIMS: Cardiolipin (CL) is a tetra-acyl phospholipid that provides structural and functional support to several proteins in the inner mitochondrial membrane. The majority of CL in the healthy mammalian heart contains four linoleic acid acyl chains (L(4)CL). A selective loss of L(4)CL is associated with mitochondrial dysfunction and heart failure in humans and animal models. We examined whether supplementing the diet with linoleic acid would preserve cardiac L(4)CL and attenuate mitochondrial dysfunction and contractile failure in rats with hypertensive heart failure. METHODS AND RESULTS: Male spontaneously hypertensive heart failurerats (21 months of age) were administered diets supplemented with high-linoleatesafflower oil (HLSO) or lard (10% w/w; 28% kilocalorie fat) or without supplemental fat (control) for 4 weeks. HLSO preserved L(4)CL and total CL to 90% of non-failing levels (vs. 61-75% in control and lard groups), and attenuated 17-22% decreases in state 3 mitochondrial respiration observed in the control and lard groups (P < 0.05). Left ventricular fractional shortening was significantly higher in HLSO vs. control (33 ± 2 vs. 29 ± 2%, P < 0.05), while plasma insulin levels were lower (5.4 ± 1.1 vs. 9.1 ± 2.3 ng/mL; P < 0.05), with no significant effect of lard supplementation. HLSO also increased serum concentrations of several eicosanoid species compared with control and lard diets, but had no effect on plasma glucose or blood pressure. CONCLUSION: Moderate consumption of HLSO preserves CL and mitochondrial function in the failing heart and may be a useful adjuvant therapy for this condition.
Authors: J Narula; P Pandey; E Arbustini; N Haider; N Narula; F D Kolodgie; B Dal Bello; M J Semigran; A Bielsa-Masdeu; G W Dec; S Israels; M Ballester; R Virmani; S Saxena; S Kharbanda Journal: Proc Natl Acad Sci U S A Date: 1999-07-06 Impact factor: 11.205
Authors: G Olivetti; R Abbi; F Quaini; J Kajstura; W Cheng; J A Nitahara; E Quaini; C Di Loreto; C A Beltrami; S Krajewski; J C Reed; P Anversa Journal: N Engl J Med Date: 1997-04-17 Impact factor: 91.245
Authors: J W Swan; S D Anker; C Walton; I F Godsland; A L Clark; F Leyva; J C Stevenson; A J Coats Journal: J Am Coll Cardiol Date: 1997-08 Impact factor: 24.094
Authors: Jason H Y Wu; Rozenn N Lemaitre; Irena B King; Xiaoling Song; Bruce M Psaty; David S Siscovick; Dariush Mozaffarian Journal: Circulation Date: 2014-08-14 Impact factor: 29.690
Authors: Christopher M Mulligan; Catherine H Le; Anthony B deMooy; Christopher B Nelson; Adam J Chicco Journal: J Gerontol A Biol Sci Med Sci Date: 2014-01-13 Impact factor: 6.053
Authors: Ranjan Banerjee; Scott J Bultman; Darcy Holley; Carolyn Hillhouse; James R Bain; Christopher B Newgard; Michael J Muehlbauer; Monte S Willis Journal: Metabolomics Date: 2015-10-01 Impact factor: 4.290
Authors: E A F Herbst; S Paglialunga; C Gerling; J Whitfield; K Mukai; A Chabowski; G J F Heigenhauser; L L Spriet; G P Holloway Journal: J Physiol Date: 2014-01-06 Impact factor: 5.182
Authors: Trisha J Grevengoed; Sarah A Martin; Lalage Katunga; Daniel E Cooper; Ethan J Anderson; Robert C Murphy; Rosalind A Coleman Journal: J Lipid Res Date: 2015-07-01 Impact factor: 5.922
Authors: Kathryn C Chatfield; Genevieve C Sparagna; Carmen C Sucharov; Shelley D Miyamoto; Jonathan E Grudis; Rebecca D Sobus; Jamie Hijmans; Brian L Stauffer Journal: J Mol Cell Cardiol Date: 2014-06-14 Impact factor: 5.000
Authors: Sung Ho Moon; David J Mancuso; Harold F Sims; Xinping Liu; Annie L Nguyen; Kui Yang; Shaoping Guan; Beverly Gibson Dilthey; Christopher M Jenkins; Carla J Weinheimer; Attila Kovacs; Dana Abendschein; Richard W Gross Journal: J Biol Chem Date: 2016-07-23 Impact factor: 5.157